Greater Cannabis Company (GCAN) Change in Account Payables (2019 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Change in Account Payables of -$1000.0 in Q1 2026, down 198.51% quarter-over-quarter from -$335.0 in Q4 2025, and down 706.06% on a YoY basis from $165.0 in Q1 2025.
Greater Cannabis Company (GCAN) Change in Account Payables (2019 - 2026) Analysis & Trends
Greater Cannabis Company's Change in Account Payables history runs 8 years deep, the most recent figure standing at -$1000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 706.06% year-over-year to -$1000.0; the TTM figure through Mar 2026 stood at -$530.0 (down 129.69% YoY), while the FY2025 annual figure was $635.0, down 64.43% from the prior year.
- Change in Account Payables was -$1000.0 for Q1 2026 at Greater Cannabis Company, down from -$335.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $5951.0 in Q3 2022 to a low of -$10259.0 in Q1 2023.
- Historically, Change in Account Payables has averaged -$246.53 across 5 years, with a median of $165.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Change in Account Payables plunged 920.72% in 2023, then jumped 157.95% in 2024.
- A 5-year view of Change in Account Payables shows it stood at $1954.0 in 2022, then surged by 40.94% to $2754.0 in 2023, then plunged by 46.95% to $1461.0 in 2024, then tumbled by 122.93% to -$335.0 in 2025, then plunged by 198.51% to -$1000.0 in 2026.
- The last three Change in Account Payables figures came in at -$1000.0 (Q1 2026), -$335.0 (Q4 2025), and $2056.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Greater Cannabis Company | - | - | - | -1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | -335.00 |
| Dec 31, 2025 | -335.00 |
| Sep 30, 2025 | 2,056.00 |
| Sep 30, 2025 | 2,056.00 |
| Jun 30, 2025 | -1,251.00 |
| Jun 30, 2025 | -1,251.00 |
| Mar 31, 2025 | 165.00 |
| Mar 31, 2025 | 165.00 |
| Dec 31, 2024 | 1,461.00 |
| Dec 31, 2024 | 1,461.00 |
| Sep 30, 2024 | 1,159.00 |
| Sep 30, 2024 | 1,159.00 |
| Jun 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 165.00 |
| Mar 31, 2024 | 165.00 |
| Dec 31, 2023 | 2,754.00 |
| Dec 31, 2023 | 2,754.00 |